GlassScriptPhysician profile
Menachem Weiss
NPI 1124524319
$4,593.46
in general payments reported to CMS, 2019-2025
18 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $554 · 2023: $1,120 · 2024: $1,355 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,039.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,227.25 | 2022-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Glaukos Corporation | $754.55 | 2022-2025 | Photrexa Viscous and Photrexa, Idosetr, Ce-Marked Kxla System |
| Biotissue Holdings INC. | $631.02 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $390.04 | 2023-2024 | Tecnis Simplicity, Amo Phaco Needle, Veritas Vision System |
| Bausch & Lomb Americas INC. | $336.60 | 2022-2025 | Stellaris, Scoutpro Osmolarity System, Xiidra |
| Abbvie INC. | $277.00 | 2023-2025 | Durysta |
| Amgen INC. | $222.16 | 2024-2025 | Tepezza |
| Ocular Therapeutix, INC. | $145.71 | 2023-2024 | Dextenza |
| Rxsight INC | $141.54 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $120.54 | 2024-2025 | |
| Thea Pharma INC. | $88.22 | 2024-2025 | Iyuzeh |
| Harrow Eye, LLC | $56.21 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $50.81 | 2023-2024 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $47.60 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $34.73 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $26.38 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Abb Con-Cise Optical Group LLC | $22.19 | 2024 | Spectacle Lenses, Contact Lens |
| Santen INC. | $20.91 | 2023 | Verkazia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Menachem Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.